Vivos Therapeutics, Inc. VVOS Q4 2025 earnings
Reported April 15, 2026
Revenue$3.8MMiss by $3.3M
EPS-$0.58Miss by $0.08
Revenue estimate$7.1M
EPS estimate-$0.50
Next report
Aug 18, 2026 (In 2 weeks)Revenue estimate$5.6M
EPS estimate-$0.42
Versus estimates
Revenue
Diluted EPS
Ask the moment Vivos Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Vivos Therapeutics, Inc. report Q4 2025 earnings?
- Vivos Therapeutics, Inc. (VVOS) reported Q4 2025 earnings on April 15, 2026.
- What were Vivos Therapeutics, Inc.'s Q4 2025 revenue and EPS?
- Vivos Therapeutics, Inc. reported revenue of $3.8M and eps of $-0.58 for Q4 2025.
- Did Vivos Therapeutics, Inc. beat estimates in Q4 2025?
- Revenue missed the consensus estimate of $7.1M by $3.3M. EPS missed the consensus estimate of $-0.49 by $0.08.
- How did Vivos Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 3.4% from $3.7M a year earlier and eps declined 107.1% from $-0.28.
- Where can I find Vivos Therapeutics, Inc.'s Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001493152-26-016865) directly on SEC EDGAR. The filing index links above go to sec.gov.